VC-backed NeuroPace goes public

Silicon Valley-based medical device company NeuroPace has raised $102 million for its IPO after pricing its 6 million shares at $17 per share.

To view this content, you need to sign in.


You should only be asked to sign in once. Not the case? Click here


Register now to access this content and more for free.

Share this